LICENSED TO HEAL

摘要

In trying to reduce the population-wide harm caused by tobacco smoking, those involved in the tobacco, tobacco replacement and nicotine sectors look, in part, at product risk but are aware that developing a product with zero- or close to zero-risk will not of itself eliminate such harm. This is clearly demonstrated by the existence of the nicotine patch. It is generally recognized that a product's risk must be set against its performance-mainly its appeal to smokers but also its efficacy in providing a replacement for cigarettes and, if possible, a gateway out of nicotine addiction, but not a gateway for nonsmokers into such addiction.